Inventor · disambiguated record
Zhongdao Li
Also filed as: LI ZHONGDAO
3 granted patents·15 pending applications·4 citations·filing 2017–2023
56Inventor score
Files withNANJING GENSCRIPT BIOTECH CO LTD15NANJING LEGEND BIOTECH CO LTD2NANJING PROBIO BIOTECH CO LTD1
Top patents by PatentIndex Score
18 records- 0183US11447573B2Multispecific antigen binding proteins and methods of use thereofNANJING LEGEND BIOTECH CO LTD·Filed 2017·Granted Sep 20, 2022·3 cites·19 claims
- 0274US11970537B2Fusion protein dimer using antibody Fc region as backbone and use thereofNANJING GENSCRIPT BIOTECH CO LTD·Filed 2018·Granted Apr 30, 2024·1 cites·17 claims
- 0366US2023059836A1Multispecific antigen binding proteins and methods of use thereofNANJING LEGEND BIOTECH CO LTD·Filed 2022·Application pending·0 cites
- 0456US2025188167A1Antibodies and variants thereof against human b7-h3NANJING PROBIO BIOTECH CO LTD·Filed 2023·Application pending·0 cites
- 0556US2024352128A1ANTIBODIES AND VARIANTS THEREOF AGAINST HUMAN CD16aNANJING GENSCRIPT BIOTECH CO LTD·Filed 2022·Application pending·0 cites
- 0653US2024182553A1Antibody fusion proteins and uses thereofNANJING GENSCRIPT BIOTECH CO LTD·Filed 2022·Application pending·0 cites
- 0752US2024148903A1Delivery of antibody by using dual viral vector systemNANJING GENSCRIPT BIOTECH CO LTD·Filed 2022·Application pending·0 cites
- 0851US2023312698A1Antibodies against human angiopoietin-2 and uses thereofNANJING GENSCRIPT BIOTECH CO LTD·Filed 2021·Application pending·0 cites
- 0947US2023093512A1Fusion proteins and uses thereofNANJING GENSCRIPT BIOTECH CO LTD·Filed 2021·Application pending·0 cites
- 1047US2023125301A1Multispecific anti-claudin-18.2 constructs and uses thereofNANJING GENSCRIPT BIOTECH CO LTD·Filed 2021·Application pending·0 cites
- 1146US12358987B2Anti-CD47/anti-PD-1 bispecific antibody, preparation method and use thereofNANJING GENSCRIPT BIOTECH CO LTD·Filed 2020·Granted Jul 15, 2025·0 cites·18 claims
- 1246US2024034784A1Antibodies targeting human claudin 18.2 and uses thereofNANJING GENSCRIPT BIOTECH CO LTD·Filed 2021·Application pending·0 cites
- 1346US2022235133A1Monoclonal antibody-cytokine fusion protein dimer and application thereofNANJING GENSCRIPT BIOTECH CO LTD·Filed 2020·Application pending·0 cites
- 1445US2022267475A1Anti-cd47/anti-tigit bispecific antibody, preparation method therefor and application thereofNANJING GENSCRIPT BIOTECH CO LTD·Filed 2020·Application pending·0 cites
- 1545US2022267436A1Anti-cd47/anti-lag-3 bispecific antibody, preparation method therefor and use thereofNANJING GENSCRIPT BIOTECH CO LTD·Filed 2020·Application pending·0 cites
- 1645US2022289848A1Anti-cd47/anti-pd-l1 multiple antigen binding proteins and methods of use thereofNANJING GENSCRIPT BIOTECH CO LTD·Filed 2020·Application pending·0 cites
- 1743US2022220204A1Anti-pd-l1/anti-lag-3 multiple antigen binding proteins and methods of use thereofNANJING GENSCRIPT BIOTECH CO LTD·Filed 2020·Application pending·0 cites
- 1843US2022332848A1Anti-cd47/anti-ctla-4 bispecific antibody and preparation method therefor and application thereofNANJING GENSCRIPT BIOTECH CO LTD·Filed 2020·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →